Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P. Riederer

Showing results (31-40 of 496) with videos related to

Pageof 50
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|February 28, 2012
The significance of neuronal lateralisation in Parkinson's diseaseP Riederer, J Sian-Hülsmann
Journal of Neural Transmission|January 1, 1981
The effects of lisuride and some other dopaminergic agonists on receptor binding in human brainG P Reynolds, P Riederer
International Pharmacopsychiatry|January 1, 1981
Tranylcypromine isomers in the treatment of Parkinson's disease. Biochemical effectsG P Reynolds, P Riederer
Journal of Neural Transmission. Supplementum|January 1, 1980
Benign and malignant types of Parkinson's disease: clinical and patho-physiological characterizationW Danielczyk, P Riederer, D Seemann
Journal of Neurology|May 23, 2003
The relevance of preclinical studies for the treatment of Parkinson's diseaseM Gerlach, P Foley, P Riederer
Journal of Neural Transmission. Supplementum|January 1, 1978
Changes of some putative neurotransmitters in human cerebral infarctionK Jellinger, P Riederer, P Kothbauer
Acta Neuropathologica|February 20, 1978
Brain monoamines in human cerebral infarcts. A preliminary studyK Jellinger, P Riederer, P Kothbauer
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisisJ Kornhuber, M Weller, P Riederer
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Neurotransmission and the ontogeny of human brainW Retz, J Kornhuber, P Riederer
Current Medicinal Chemistry|July 29, 2004
Clinical applications of MAO-inhibitorsP Riederer, L Lachenmayer, G Laux
Pageof 50

Showing results (31-40 of 496) with videos related to

Sort By:
Pageof 50
Journal of Neural Transmission (Vienna, Austria : 1996)|February 28, 2012
The significance of neuronal lateralisation in Parkinson's diseaseP Riederer, J Sian-Hülsmann
Journal of Neural Transmission|January 1, 1981
The effects of lisuride and some other dopaminergic agonists on receptor binding in human brainG P Reynolds, P Riederer
International Pharmacopsychiatry|January 1, 1981
Tranylcypromine isomers in the treatment of Parkinson's disease. Biochemical effectsG P Reynolds, P Riederer
Journal of Neural Transmission. Supplementum|January 1, 1980
Benign and malignant types of Parkinson's disease: clinical and patho-physiological characterizationW Danielczyk, P Riederer, D Seemann
Journal of Neurology|May 23, 2003
The relevance of preclinical studies for the treatment of Parkinson's diseaseM Gerlach, P Foley, P Riederer
Journal of Neural Transmission. Supplementum|January 1, 1978
Changes of some putative neurotransmitters in human cerebral infarctionK Jellinger, P Riederer, P Kothbauer
Acta Neuropathologica|February 20, 1978
Brain monoamines in human cerebral infarcts. A preliminary studyK Jellinger, P Riederer, P Kothbauer
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisisJ Kornhuber, M Weller, P Riederer
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Neurotransmission and the ontogeny of human brainW Retz, J Kornhuber, P Riederer
Current Medicinal Chemistry|July 29, 2004
Clinical applications of MAO-inhibitorsP Riederer, L Lachenmayer, G Laux
Pageof 50